Diagnosing mass-transfer limitation in an immobilised β-galactosidase packed bed
β-Galactosidase from Kluyveromyces lactis is immobilised on 500 µm chitosan beads and packed into a 2.5 cm internal diameter column with a 20 cm bed height for continuous lactose hydrolysis in whey permeate at 30 °C. At a fixed space time of 10 min, conversion varies with flow rate as follows: 38% at 0.5 mL/min, 52% at 1.0 mL/min, 61% at 2.0 mL/min, 64% at 4.0 mL/min and 65% at 8.0 mL/min. At 8 mL/min the pressure drop is 1.8 bar, and the top 2 cm of beads shows visible compression. Free enzyme in the same buffer has Km = 12 mM and would give 95% conversion at this space time in a stirred batch reactor. The target is at least 85% conversion sustained for 30 days. A proposal is to halve the bead diameter to 250 µm and double the bed height to keep the same residence time.
1. Diagnose the type of limitation from the flow-rate data, and explain what it implies about the apparent kinetic parameters of the immobilised preparation.
Read the worked answer
Reading the data. Space time is constant, so if the reaction were kinetically controlled, conversion would be independent of flow rate. Instead conversion rises steeply from 38% to 61% between 0.5 and 2.0 mL/min and then plateaus at about 65% above 4 mL/min. That flow dependence is the classic signature of external film (boundary-layer) diffusion limitation: raising the linear velocity thins the stagnant film around each bead, raising the substrate flux to the surface at the same residence time.
What the plateau means. Once the film resistance is largely removed above 4 mL/min, conversion still sits at 65% against 95% for free enzyme under identical bulk conditions. The residual gap cannot be external, so internal (pore) diffusion limitation remains: substrate is consumed before it penetrates the bead core.
Kinetic consequences. The apparent Km will be higher than 12 mM, because the observed rate at a given bulk concentration is depressed more at low substrate; the apparent Vmax will be lower; and the apparent activation energy will be lower than the true value, typically around 20–30 versus 45–55 kJ/mol, because diffusion has a weak temperature dependence. Reporting the free-enzyme Km for the immobilised catalyst would therefore overestimate the bed volume needed at low lactose concentrations.
2. Evaluate the proposal quantitatively: what happens to conversion, pressure drop and bed stability, and would it meet the 85% target?
Read the worked answer
Conversion. Halving the particle diameter halves the Thiele modulus and roughly doubles the internal effectiveness factor in the strongly diffusion-limited regime, and it doubles the external surface area per unit bed volume. Together these should move conversion from about 65% toward the free-enzyme value, plausibly into the mid-80s, so the target is reachable in principle.
Pressure drop. In the laminar (Kozeny–Carman) regime, pressure drop per unit bed length scales as 1/dp², so halving dp quadruples it; doubling the bed length doubles it again. Starting from 1.8 bar, the prediction is roughly 14–15 bar. The same flow per unit area is assumed because the residence time is fixed and the column diameter is unchanged, so this is the realistic estimate.
Stability. The current bed already compresses at 1.8 bar, so a 14 bar operating pressure on a soft chitosan support is not credible: the bed will compress further, channelling will develop, and the effective bed height and residence time will drift during a 30-day run. Smaller soft beads also increase the risk of fines generation and of the bed lifting on depressurisation.
Verdict. The physics is right but the mechanical design is not. The proposal should not be implemented with the current support.
3. Suggest alternative or complementary changes that would close the gap to 85%, and describe how you would verify that the improvement is real.
Read the worked answer
Alternatives. (1) Keep the particle size but use a rigid support (cross-linked agarose, silica or a ceramic monolith), which allows smaller dimensions without compression; a monolith also decouples pressure drop from flow, removing external limitation at high velocity. (2) Increase bed length at the same linear velocity, i.e. increase residence time rather than flow, which raises conversion but also pressure drop; this is only viable with a rigid support. (3) Use two packed beds in series with interstage cooling, giving a longer effective residence time at moderate pressure. (4) Raise the operating temperature modestly to increase the intrinsic rate, accepting a shorter enzyme half-life, which must be traded against the 30-day stability target. (5) Reduce the feed lactose concentration or pre-hydrolyse part of the stream, moving the operating point away from saturation.
Verification. The decisive test is a flow-rate series at constant space time on the new configuration. If conversion becomes independent of flow above a modest velocity, external limitation has been removed; if conversion then approaches the free-enzyme value, internal limitation has also been removed. Measure the effectiveness factor directly by running identical catalyst masses at three particle sizes and plotting initial rate against 1/dp. Finally, run the chosen configuration for 30 days and track conversion, pressure drop and enzyme leakage, because a configuration that passes on day one but compresses or fouls by day ten does not meet the target.